Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Canellos

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
Blood|December 1, 1977
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvementA T Skarin, K S Zuckerman, S W Pitman, et al.
Cancer Chemotherapy Reports|September 1, 1973
High-dose intermittent intravenous infusion of procarbazine (NSC-77213)B A Chabner, R Sponzo, S Hubbard, et al.
Leukemia & Lymphoma|September 13, 2006
Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906Sonali M Smith, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Progress in Hematology|January 1, 1987
Monoclonal antibodies: their use in bone marrow transplantationK C Anderson, L M Nadler, T Takvorian, et al.
Lancet (London, England)|August 25, 1984
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphomaL M Nadler, T Takvorian, L Botnick, et al.
Cancer Treatment Reports|November 1, 1979
Treatment of acute nonlymphocytic leukemia with neocarzinostatinT W Griffin, T A Lister, M E Rybak, et al.
The Journal of Urology|January 1, 1992
Long-term followup of 150 patients with testicular cancer treated at a single institutionP W Kantoff, L A Kalish, P McDowell-Bryant, et al.
Cancer|December 15, 1982
Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer InstituteT Anderson, V T DeVita, R M Simon, et al.
Cancer|August 15, 1991
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimensC L Shapiro, B Y Yeap, J Godleski, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
Blood|December 1, 1977
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvementA T Skarin, K S Zuckerman, S W Pitman, et al.
Cancer Chemotherapy Reports|September 1, 1973
High-dose intermittent intravenous infusion of procarbazine (NSC-77213)B A Chabner, R Sponzo, S Hubbard, et al.
Leukemia & Lymphoma|September 13, 2006
Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906Sonali M Smith, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Annals of Internal Medicine|October 1, 1976
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphomaP S Schein, V T DeVita, S Hubbard, et al.
Progress in Hematology|January 1, 1987
Monoclonal antibodies: their use in bone marrow transplantationK C Anderson, L M Nadler, T Takvorian, et al.
Lancet (London, England)|August 25, 1984
Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphomaL M Nadler, T Takvorian, L Botnick, et al.
Cancer Treatment Reports|November 1, 1979
Treatment of acute nonlymphocytic leukemia with neocarzinostatinT W Griffin, T A Lister, M E Rybak, et al.
The Journal of Urology|January 1, 1992
Long-term followup of 150 patients with testicular cancer treated at a single institutionP W Kantoff, L A Kalish, P McDowell-Bryant, et al.
Cancer|December 15, 1982
Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer InstituteT Anderson, V T DeVita, R M Simon, et al.
Cancer|August 15, 1991
Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimensC L Shapiro, B Y Yeap, J Godleski, et al.
Pageof 32